Evidence map›Paper›PMID 36054531›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2023

In vitro cytocompatibility and antibacterial studies on biodegradable Zn alloys supplemented by a critical assessment of direct contact cytotoxicity assay.

Maria Wątroba, Wiktor Bednarczyk, Piotr K Szewczyk, Jakub Kawałko, Krzysztof Mech, Alina Grünewald, Irem Unalan, Nicola Taccardi, Gabriela Boelter, Manuel Banzhaf and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Maria WątrobaLaboratory for Mechanics of Materials and Nanostructures, Empa, Swiss Federal Laboratories for Materials Science and Technology, Thun, Switzerland.ORCID 0000-0003-4851-8899
Wiktor BednarczykFaculty of Materials Science and Engineering, Warsaw University of Technology, Warsaw, Poland.ORCID 0000-0003-0001-1693
Piotr K SzewczykFaculty of Metals Engineering and Industrial Computer Science, AGH University of Science and Technology, Krakow, Poland.ORCID 0000-0002-9980-5655
Jakub KawałkoAcademic Centre for Materials and Nanotechnology, AGH University of Science and Technology, Krakow, Poland.ORCID 0000-0001-5469-2338
Krzysztof MechAcademic Centre for Materials and Nanotechnology, AGH University of Science and Technology, Krakow, Poland.ORCID 0000-0002-0119-8456
Alina GrünewaldDepartment of Materials Science and Engineering, Institute of Biomaterials, University of Erlangen-Nuremberg, Erlangen, Germany.
Irem UnalanDepartment of Materials Science and Engineering, Institute of Biomaterials, University of Erlangen-Nuremberg, Erlangen, Germany.ORCID 0000-0002-4729-0012
Nicola TaccardiInstitute of Chemical Reaction Engineering, University of Erlangen-Nuremberg, Erlangen, Germany.ORCID 0000-0002-4682-7332
Gabriela BoelterInstitute of Microbiology and Infection and School of Biosciences, University of Birmingham, Birmingham, UK.ORCID 0000-0002-1812-8681
Manuel BanzhafInstitute of Microbiology and Infection and School of Biosciences, University of Birmingham, Birmingham, UK.ORCID 0000-0002-4682-1037
Caroline HainLaboratory for Mechanics of Materials and Nanostructures, Empa, Swiss Federal Laboratories for Materials Science and Technology, Thun, Switzerland.ORCID 0000-0002-5897-6335
Piotr BałaFaculty of Metals Engineering and Industrial Computer Science, AGH University of Science and Technology, Krakow, Poland.ORCID 0000-0002-9896-6350
Aldo R BoccacciniDepartment of Materials Science and Engineering, Institute of Biomaterials, University of Erlangen-Nuremberg, Erlangen, Germany.ORCID 0000-0002-7377-2955
AGH University of Krakow · PLFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of Birmingham · GBBern University of Applied Sciences · CHWarsaw University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vitro cytotoxicity assessment is indispensable in developing new biodegradable implant materials. Zn, which demonstrates an ideal corrosion rate between Mg- and Fe-based alloys, has been reported to have excellent in vivo biocompatibility. Therefore, modifications aimed at improving Zn's mechanical properties should not degrade its biological response. As sufficient strength, ductility and corrosion behavior required of load-bearing implants has been obtained in plastically deformed Zn-3Ag-0.5Mg, the effect of simultaneous Ag and Mg additions on in vitro cytocompatibility and antibacterial properties was studied, in relation to Zn and Zn-3Ag. Direct cell culture on samples and indirect extract-based tests showed almost no significant differences between the tested Zn-based materials. The diluted extracts of Zn, Zn-3Ag, and Zn-3Ag-0.5Mg showed no cytotoxicity toward MG-63 cells at a concentration of ≤12.5%. The cytotoxic effect was observed only at high Zn

Indexed as

Absorbable ImplantsAlloysAnti-Bacterial AgentsBiocompatible MaterialsCell LineCorrosionEscherichia coliIonsMaterials TestingTetrazolium SaltsZincAlloysAnti-Bacterial AgentsBiocompatible MaterialsIonsTetrazolium SaltsZincantibacterial propertiesbiodegradationcytotoxicitytetrazolium salt-based assayZn alloys

Identifiers

PMID36054531
PMCPMC10086991
OpenAlexW4293175726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.